Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03377127 · ClinicalTrials.gov registry record · NA

Impact of Pharmacy Clinic on Diabetes Management

A NA study, sponsored by Corewell Health East.

Completed
Registry status
NA
Development phase
86
Enrollment target

NCT03377127 is a NA study that has completed, run by Corewell Health East. The registered enrollment target is 86 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03377127, a NA study, has completed, sponsored by Corewell Health East.

COMPLETED
Registry status
NA
Development phase
86 participants
Enrollment target

Study Summary

The Beaumont Hospital Royal Oak Outpatient Clinic (and other listed Beaumont recruiting locations) care for over 900 patients with diabetes. In an effort to improve the care provided to our patients, a pharmacist managed diabetes clinic (PMDC) was created. The investigators looked at patients with high-risk diabetes who have received education in the PMDC and compared them to patients that didn't not receive the pharmacy education. Our preliminary data showed a significant decrease in Hemoglobin A1c in the PMDC compared to our standard care cohort. Hemoglobin A1c is a marker of the severity of diabetes mellitus. Based on this data, we designed a randomized controlled trial to better assess the impact of a PMDC on diabetic outcomes.

Interventions

  • OTHER Standard of Care (SOC)
  • BEHAVIORAL Pharmacy Managed Diabetes Clinic (PMDC)

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2018-02-19
Est. Completion 2020-11-30
Phase NA

Sponsor

Corewell Health East

106 total trials

What the Registry Record Tells You About NCT03377127

The ClinicalTrials.gov registry entry for NCT03377127 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Standard of Care (SOC) is the first listed.

NCT03377127 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03377127 about?

NCT03377127 is a clinical study titled "Impact of Pharmacy Clinic on Diabetes Management". The Beaumont Hospital Royal Oak Outpatient Clinic (and other listed Beaumont recruiting locations) care for over 900 patients with diabetes. In an effort to improve the care provided to our patients, a pharmacist managed diabetes clinic (PMDC) was created. The investigators looked at patients with h...

What is the current status of trial NCT03377127?

This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2018-02-19. Estimated completion is 2020-11-30.

What interventions are being tested in trial NCT03377127?

The interventions under investigation include: Standard of Care (SOC) (OTHER), Pharmacy Managed Diabetes Clinic (PMDC) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03377127?

This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.